Market Overview:
Air pressure therapy includes both sequential compression device (SCD) and intermittent pneumatic compression (IPC). SCD delivers sequential pulses of air pressure from the ankles or feet up the leg, promoting blood flow back to the heart. IPC delivers targeted compression to the lower leg, calf or foot via an inflatable cuff connected to a pump unit. These devices are used primarily for deep vein thrombosis (DVT) prophylaxis, lymphedema management, and chronic venous insufficiency. They provide an effective non-pharmacological alternative to conventional compression therapy. The growing prevalence of chronic diseases, increasing geriatric population and rising number of surgical procedures are key factors driving demand for air pressure therapy.

Market Dynamics:
The rising prevalence of chronic venous insufficiency and lymphedema are expected to be a key driver boosting the air pressure therapy market growth during the forecast period. According to the estimates of the Centers for Disease Control and Prevention (CDC), approximately 30-50 million adults aged 40 years and above suffer from chronic venous insufficiency in the United States alone. Lymphedema incidence has also been rising with advancing age and increasing cancer cases.

For example, according the National Cancer Institute, about 20 million people in the United States have a history of cancer today. Lymphedema is a common side effect of cancer treatment. Sequential compression devices and intermittent pneumatic compression equipment can help manage both these chronic conditions effectively and reduce healthcare costs associated with reoccurrence. Moreover, growing number of surgical procedures is another driver fueling demand. Surgical procedures are associated with increased risks of DVT, especially knee and hip replacement surgeries. Air pressure therapy plays an important role in preventing DVT post-surgery and speeding up recovery, thereby supporting its adoption.

The global Air Pressure Therapy Market Growth is estimated to be valued at US$ 4.4 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

SWOT Analysis
Strength: The air pressure therapy market has seen consistent technological advancements which has improved efficacy and user experience. The non-invasive nature of air pressure therapy makes it a preferred treatment option. Growing base of clinical evidences further supports the clinical benefits of air pressure therapy.
Weakness: Higher costs of advanced air pressure therapy products restricts its adoption in price sensitive markets. Lack of insurance coverage or partial coverage also acts as a deterrent for many patients.
Opportunity: Increasing incidence of lymphedema, deep vein thrombosis and other conditions indicate potential for volume growth. Growing geriatric population prone to such conditions augurs well for long term demand. Additionally, market expansion opportunities lie in developing regions owing to growing medical infrastructure and awareness.
Threats: Stiff competition from alternative compression therapy technologies limits pricing flexibility of key players. Stringent regulatory approvals and quality standards continue to raise entry barriers for new entrants.

Key Takeaways
The global air pressure therapy market is expected to witness high growth, exhibiting CAGR of 6.3% over the forecast period, due to increasing incidence of lymphedema, deep vein thrombosis and other conditions requiring compression therapy.

Regional analysis
North America dominated the global market in 2021 with over 35% revenue share owing to advanced healthcare facilities and favorable reimbursement structure in countries like US and Canada. Asia Pacific is projected to witness highest growth rate during the forecast period supported by expanding medical infrastructure, rising medical tourism and growing health awareness in major economies like India and China.

Key players
Key players operating in the air pressure therapy market are DJO Global, Inc., BSN medical (now part of Essity), Smith & Nephew plc, medi GmbH & Co. KG, SIGVARIS Group, Bio Compression Systems, Inc., Tactile Medical, RIKEN SEIKI CO., LTD., Paul Hartmann AG, 3M Company, Gottfried Medical, Inc., Mego Afek AC Ltd., Abov Semiconductor, Persys Medical, BTL Industries, Human Meditek Co., Ltd., Huntleigh Healthcare Limited (part of Arjo), KCI Licensing, Inc., Beijing Huibo Medical Device Co., Ltd., Bioinicia S.L. The major players are focusing on new product development and geographic expansion to solidify their market presence.

Read More: https://blogger-veritas.blogspot.com/2023/11/air-pressure-therapy-is-fastest-growing.html